ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 161 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $117,539,000 | +20.1% | 3,418,861 | +0.8% | 0.10% | +17.1% |
Q4 2016 | $97,834,000 | -3.8% | 3,392,171 | +6.1% | 0.08% | -4.7% |
Q3 2016 | $101,699,000 | -2.1% | 3,197,082 | -0.1% | 0.09% | -2.3% |
Q2 2016 | $103,923,000 | +37.8% | 3,201,615 | +18.7% | 0.09% | +35.4% |
Q1 2016 | $75,439,000 | +30.1% | 2,698,066 | +65.9% | 0.06% | +32.7% |
Q4 2015 | $57,976,000 | -45.9% | 1,626,247 | -49.8% | 0.05% | +2.1% |
Q3 2015 | $107,116,000 | -15.3% | 3,239,074 | +7.2% | 0.05% | -53.8% |
Q2 2015 | $126,499,000 | +37.9% | 3,020,512 | +7.3% | 0.10% | +38.7% |
Q1 2015 | $91,713,000 | +8.9% | 2,814,149 | +6.1% | 0.08% | +4.2% |
Q4 2014 | $84,245,000 | +30.2% | 2,653,382 | +1.5% | 0.07% | +22.0% |
Q3 2014 | $64,706,000 | +118.2% | 2,613,343 | +99.1% | 0.06% | +118.5% |
Q2 2014 | $29,654,000 | -0.9% | 1,312,725 | +6.7% | 0.03% | -3.6% |
Q1 2014 | $29,921,000 | +28.3% | 1,229,809 | +31.8% | 0.03% | +27.3% |
Q4 2013 | $23,315,000 | – | 932,993 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |